Abbott Wins Unrestricted Use Of Stent Patent
A federal judge has adopted Abbott Laboratories's interpretation of its settlement of a coronary stent patent dispute with Medinol Ltd., finding that Abbott may exploit the patent however it pleases rather...To view the full article, register now.
Already a subscriber? Click here to view full article